A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs.

Oncotarget

Volumn 1, Issue 4, 2010, Pages 252-264

  Murai, Ryuya ^a   Yoshida, Yoko ^b   Muraguchi, Teruyuki ^b   Nishimoto, Emi ^b   Morioka, Yoko ^b   Kitayama, Hitoshi ^b   Kondoh, Shinae ^b   Kawazoe, Yoshinori ^b   Hiraoka, Masahiro ^b   Uesugi, Motonari ^b   Noda, Makoto ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; DISULFIRAM; DOXYCYCLINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HRAS PROTEIN, HUMAN; PROTEIN P21; RECK PROTEIN, HUMAN;

ANIMAL; ARTICLE; CELL PROLIFERATION; DRUG DEVELOPMENT; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOBLOTTING; METASTASIS; METHODOLOGY; MOUSE; PROGNOSIS; PROMOTER REGION; RAT; TUMOR CELL LINE;

ALKALINE PHOSPHATASE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DISULFIRAM; DOXYCYCLINE; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; IMMUNOBLOTTING; MICE; NEOPLASM METASTASIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS P21(RAS); RATS;

EID: 80052055075     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.136     Document Type: Article

References (0)